Purdue Pharma offers $10-12bn opioid claims settlement: reports

Purdue

Purdue Pharma, the maker of opioid-containing painkiller OxyContin, has offered to pay $10-12bn to settle some 2,000 claims against it, accusing the pharmaceutical company of employing deceptive sales techniques and fueling the opioid crisis of the 2000s.

Want to read this article?

Subscribe for FULL access to this article - and ALL our premium content

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey
Commercial director
Email: spencer.halladey@wbmediagroup.com
Tel: +44 (0) 203 934 6687

Andy Stone
Sales manager
Email: andy.stone@wbmediagroup.com
Tel: +44 (0) 203 934 6684

Subscribers get access to:

  • Breaking news by email on all critical issues
  • Trusted analysis and commentary
  • Opinion from market thought-leaders
  • Exclusive data on the industry
  • Daily digital newsletter
  • Full access to our online archive

 

If you are a subscriber you can SIGN IN now for FULL access